CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 18:44 UTC

The Annexure

Desk Healthcare Rekvina Laboratories Ltd

Rekvina Laboratories Ltd

BSE 526075 VINRKLB INE092O01028
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 61 trading days

17 filings · 3 material · busiest 2026-06-30

What it files

Filings

17 in the window

  1. 18 August 2026

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Surbhit Mukesh Shah & Others

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  2. 17 August 2026

    SAST

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhruvalkumar Patel

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

  3. 14 August 2026

    General

    Clarification On Price Movement

    Clarification on Price Movement

    Company Update / General View filing →

  4. 13 August 2026

    Board Outcome

    Board Meeting Outcome for OUTCOME OF BOARD MEETING

    OUTCOME OF BOARD MEETING

    Board Meeting / Outcome of Board Meeting View filing →

  5. 13 August 2026

    Results

    FINANCIAL RESULTS QTR1

    FINANCIAL RESULT QTR1

    Result / Financial Results View filing →

  6. 12 August 2026

    Allotment

    Allotment

    Allotment of Equity Shares on Preferential basis

    Company Update / Allotment of Equity Shares View filing →

  7. 12 August 2026

    Clarification

    Clarification sought from Rekvina Laboratories Ltd

    The Exchange has sought clarification from Rekvina Laboratories Ltd on August 12, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....

    Company Update / Clarification

  8. 31 July 2026

    General

    Post Offer Advertisement

    Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Post Offer Advertisement in accordance with Regulation 18(12) of the Securities Exchange Board ....

    Company Update / General View filing →

  9. 15 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance Certificate under Reg 74(5) of SEBI (DP) Regulation 2018

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  10. 30 June 2026

    Trading Window

    Closure of Trading Window

    Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  11. 30 June 2026

    General

    Pre-Offer Advertisement & Corrigendum to Detailed Public Statement

    Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of The Securities and Exchange ....

    Company Update / General View filing →

  12. 30 June 2026

    Open Offer Update

    Open Offer - Updates

    Open Offer Update

    Company Update / Open Offer - Updates View filing →

  13. 25 June 2026

    Open Offer Update

    Open Offer - Updates

    Newspaper Advertisement

    Company Update / Open Offer - Updates View filing →

  14. 25 June 2026

    Open Offer

    Updates on Open Offer

    Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors in accordance with Regulation 26(7) ....

    Company Update / Open Offer View filing →

  15. 24 June 2026

    Open Offer Update

    Open Offer - Updates

    Recommendations of the Committee of Independent Directors of Company under Regulation 26(7) of SEBI (SAST) Regulation, 2011

    Company Update / Open Offer - Updates View filing →

  16. 23 June 2026

    General

    Letter of Offer

    Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Equity Shareholders of Rekvina Laboratories Ltd ("'Target ....

    Company Update / General View filing →

  17. 23 June 2026

    Open Offer Update

    Open Offer - Updates

    We wish to inform you that the company has received a copy of the letter of offer issued by Vivro Financial Services Private Limited in relation to open offer to the Public Shareholders.

    Company Update / Open Offer - Updates View filing →